DEFINITIVE PROXY STATEMENTS

Company

Oncotelic Therapeutics, Inc.

Filed

April 30, 1998

Period of Report

April 21, 1998

Accession Number

0000914121-98-000322

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →